These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 25225003)

  • 21. A Comparative Observational Study to Evaluate the Efficacy of Mid-Urethral Sling with Botulinum Toxin A Injection in Urinary Incontinence Patients.
    Chang YH; Hsiao PJ; Chi-Ping H; Wu HC; Hsieh PF; Chou EC
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32498306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Traditional suburethral sling operations for urinary incontinence in women.
    Rehman H; Bezerra CC; Bruschini H; Cody JD
    Cochrane Database Syst Rev; 2011 Jan; (1):CD001754. PubMed ID: 21249648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Open retropubic colposuspension for urinary incontinence in women: a short version Cochrane review.
    Lapitan MC; Cody JD; Grant A
    Neurourol Urodyn; 2009; 28(6):472-80. PubMed ID: 19591206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis.
    Lee JK; Dwyer PL; Rosamilia A; Lim YN; Polyakov A; Stav K
    BJOG; 2011 Jun; 118(7):798-805. PubMed ID: 21392244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Update on current care guidelines: urinary incontinence (female)].
    Duodecim; 2012; 128(6):610-1. PubMed ID: 22506323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors Associated with Therapeutic Efficacy of Intravesical OnabotulinumtoxinA Injection for Overactive Bladder Syndrome.
    Hsiao SM; Lin HH; Kuo HC
    PLoS One; 2016; 11(1):e0147137. PubMed ID: 26824901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Female urinary incontinence: effective treatment strategies.
    Castro RA; Arruda RM; Bortolini MA
    Climacteric; 2015 Apr; 18(2):135-41. PubMed ID: 25307986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of different protocols of pelvic floor physical therapy and anti-cholinergics in women with wet over-active bladder: A 4-year follow-up.
    Azuri J; Kafri R; Ziv-Baran T; Stav K
    Neurourol Urodyn; 2017 Mar; 36(3):755-758. PubMed ID: 27080326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of urgency severity is the most important factor in the subjective therapeutic outcome of intravesical onabotulinumtoxinA injection for overactive bladder.
    Jiang YH; Kuo HC
    Neurourol Urodyn; 2017 Feb; 36(2):338-343. PubMed ID: 26575613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gynecology: urinary incontinence - mini-review and case reports].
    Scheiner D; Perucchini D; Fink D; Betschart C
    Praxis (Bern 1994); 2012 Apr; 101(9):585-92. PubMed ID: 22535454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systematic review: randomized, controlled trials of nonsurgical treatments for urinary incontinence in women.
    Shamliyan TA; Kane RL; Wyman J; Wilt TJ
    Ann Intern Med; 2008 Mar; 148(6):459-73. PubMed ID: 18268288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overactive bladder syndrome - management and treatment options.
    Arnold J; McLeod N; Thani-Gasalam R; Rashid P
    Aust Fam Physician; 2012 Nov; 41(11):878-83. PubMed ID: 23145420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pelvic Floor Dysfunction And Its Effect On Quality Of Sexual Life.
    Verbeek M; Hayward L
    Sex Med Rev; 2019 Oct; 7(4):559-564. PubMed ID: 31351916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can we predict if overactive bladder symptoms will resolve after sling surgery in women with mixed urinary incontinence?
    Katsumi HK; Rutman MP
    Curr Urol Rep; 2010 Sep; 11(5):328-37. PubMed ID: 20632135
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-incision sling operations for urinary incontinence in women.
    Nambiar A; Cody JD; Jeffery ST
    Cochrane Database Syst Rev; 2014 Jun; (6):CD008709. PubMed ID: 24880654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OnabotulinumtoxinA for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial.
    Nitti VW; Dmochowski R; Herschorn S; Sand P; Thompson C; Nardo C; Yan X; Haag-Molkenteller C;
    J Urol; 2013 Jun; 189(6):2186-93. PubMed ID: 23246476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence.
    Panayi DC; Duckett J; Digesu GA; Camarata M; Basu M; Khullar V
    Neurourol Urodyn; 2009; 28(1):82-5. PubMed ID: 19089898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial.
    Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C
    Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy in overactive bladder-untapped research opportunities: A systematic review of the literature.
    Kasman A; Stave C; Elliott CS
    Neurourol Urodyn; 2019 Nov; 38(8):2083-2092. PubMed ID: 31483070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of mixed urinary incontinence.
    Grimshaw R; Jain P; Latthe P
    Womens Health (Lond); 2012 Sep; 8(5):567-77. PubMed ID: 22934730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.